Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
31
NCT00327652
Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 31, 2006
Completion: Not specified
NCT00585845
Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment
Start: Dec 31, 2007
Completion: Feb 28, 2009
NCT00800007
Study of Safety and Tolerability of Multiple Intravenous Doses of ANZ-521 in Adults With Chronic Hepatitis C Virus
Phase: Phase 1/2
Start: Nov 30, 2008